Skip to main content
Clinical Trials/NCT00290368
NCT00290368
Completed
Phase 2

Assessment of Inflammatory Mediator and Cellular Changes Following Repeated Nasal Allergen Challenge in Subjects With Allergic Rhinitis Sensitive to Timothy Grass Pollen - a Validation Study

Imperial College London1 site in 1 country22 target enrollmentFebruary 2006
ConditionsHayfever

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Hayfever
Sponsor
Imperial College London
Enrollment
22
Locations
1
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled allergen, which will more closely resemble the responses seen during the hayfever season.

Detailed Description

This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled allergen, which will more closely resemble the responses seen during the hayfever season.

Registry
clinicaltrials.gov
Start Date
February 2006
End Date
May 2006
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects with a history of seasonal (intermittent) atopic rhinitis, aged 18-40 years.
  • Otherwise healthy with no health problems that may jeopardize the subjects participating in the study, absence of history of other significant allergies.

Exclusion Criteria

  • Smokers (use of tobacco products in the previous 3 months).
  • Presence of any respiratory disease other than a history of mild stable asthma not requiring treatment and associated with normal lung function (FEV1 \> 80% predicted at screening).

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials